Dana-Farber Cancer Institute — Boston, Massachusetts

Dana-Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute has participated in 2029 clinical trials with 704 currently active.

Therapeutic areas: Neoplasms, Carcinoma, Non Small Cell Lung, Breast Neoplasms.

Sponsors: Pfizer, Regeneron Pharmaceuticals, Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute?

Dana-Farber Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute conducted?

Dana-Farber Cancer Institute has 2029 clinical trials on record, with 704 currently active. Their work covers Neoplasms, Carcinoma, Non Small Cell Lung, Breast Neoplasms.

Is Dana-Farber Cancer Institute accredited by Crixeo Health?

Dana-Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.